Your prediction
Pros and Cons of Eagle Pharmaceuticals Inc in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Eagle Pharmaceuticals Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Eagle Pharmaceuticals Inc | - | - | - | - | - | - | - |
| Rockwell Medical Inc. | -0.860% | -9.302% | -19.863% | -36.859% | -13.525% | -83.043% | -92.789% |
| Pacira Pharmaceuticals | -0.530% | -7.767% | -12.037% | -15.179% | -12.037% | -46.927% | -62.376% |
| Twist Bioscience Corp | 2.720% | 12.935% | 25.307% | 129.529% | 123.842% | 309.324% | -21.248% |
Comments
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) was downgraded by analysts at Piper Sandler from a "neutral" rating to an "underweight" rating.
Show more
Ratings data for EGRX provided by MarketBeat
